← Leaderboards
Derrick J. Rossi
Stanford University
$6,969,300
Attributed
$14,469,822
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3M · FY2007–19$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$14,469,822 · 5
By mechanism
U01$9,000,626 · 1
R01$2,526,697 · 1
U19$2,128,073 · 1
R00$744,510 · 1
K99$69,916 · 1
Top collaborators
- Chad Albert Cowan5 shared
- Robert E Gerszten5 shared
- Sekar Kathiresan5 shared
- Vasan S. Ramachandran5 shared
- Rahul Chandrakant Deo3 shared
- Frederick P Roth2 shared
Most similar at Stanford University
Same institution · by research overlap
- Camilla Forsberg$12,445,804
- Helen M Blau$36,149,136
- Kelley Yan$6,007,087
- Chad E Bennett$478,366
- Ching-Cheng Chen$919,380
Others in their field
Top investigators on “Stem”
- Mary M Horowitz · Medical College Of Wisconsin$220,248,453
- Lisa Garcia Bedolla · University Of California-Berkeley$175,927,128
- David Heimbrook · Leidos Biomedical Research, Inc.$160,503,300
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Kenneth E Goodson · Stanford University$123,393,510
- Stacey F Bent · Stanford University$102,348,752
Research focus
StemStem CellsGenesPathway InteractionsEffector CellMediatingHematopoietic Stem CellsPositioning AttributeCellsGenerationsHematopoieticAbstractingLipidsInsightImmuneInduced Pluripotent Stem CellIn VitroGeneticFrequencies (Time Pattern)AffectBlood CellsGenomicsBone Marrow TransplantationExhaustion
Grant awards (20)
Engineering stem and effector cells towards a functional HIV-1 cure$342,273
U19 · FY2019 · HL · contact PI
Engineering stem and effector cells towards a functional HIV-1 cure$442,500
U19 · FY2018 · HL · contact PI
Engineering stem and effector cells towards a functional HIV-1 cure$442,500
U19 · FY2017 · HL · contact PI
Engineering stem and effector cells towards a functional HIV-1 cure$442,500
U19 · FY2016 · HL · contact PI
Integrating lipid genotyes and phenotypes in iPS derived hepatocytes/adipocytes$2,033,252
U01 · FY2015 · HL
Reprogramming committed blood cells to a hematopoietic stem cell fate$496,111
R01 · FY2015 · HL · contact PI
Engineering stem and effector cells towards a functional HIV-1 cure$458,300
U19 · FY2015 · HL · contact PI
Integrating lipid genotyes and phenotypes in iPS derived hepatocytes/adipocytes$2,441,919
U01 · FY2014 · HL
Reprogramming committed blood cells to a hematopoietic stem cell fate$493,594
R01 · FY2014 · HL · contact PI
Integrating lipid genotyes and phenotypes in iPS derived hepatocytes/adipocytes$2,334,891
U01 · FY2013 · HL
Reprogramming committed blood cells to a hematopoietic stem cell fate$479,492
R01 · FY2013 · HL · contact PI
Integrating lipid genotyes and phenotypes in iPS derived hepatocytes/adipocytes$1,337,440
U01 · FY2012 · HL
Reprogramming committed blood cells to a hematopoietic stem cell fate$380,565
R01 · FY2012 · HL · contact PI
Reprogramming committed blood cells to a hematopoietic stem cell fate$148,185
R01 · FY2012 · HL · contact PI
Integrating lipid genotyes and phenotypes in iPS derived hepatocytes/adipocytes$853,124
U01 · FY2011 · HL
Reprogramming committed blood cells to a hematopoietic stem cell fate$528,750
R01 · FY2011 · HL · contact PI
Stem Cell Aging: Functional Decline, DNA damage and Therapeutic Targets$246,510
R00 · FY2010 · AG · contact PI
Stem Cell Aging: Functional Decline, DNA damage and Therapeutic Targets$249,000
R00 · FY2009 · AG · contact PI
Stem Cell Aging: Functional Decline, DNA damage and Therapeutic Targets$249,000
R00 · FY2008 · AG · contact PI
Stem Cell Aging: Functional Decline, DNA damage and Therapeutic Targets$69,916
K99 · FY2007 · AG · contact PI